COST-EFFECTIVENESS OF A FIXED DOSE COMBINATION OF ALENDRONATE AND CHOLECALCIFEROL IN THE TREATMENT OF WOMEN WITH OSTEOPOROSIS AT RISK FOR VITAMIN D DEFICIENCY

被引：0
|
作者：
Ghosh, Sabyasachi [1 ]
Fan, Tao [2 ]
Modi, Ankita [2 ]
Jansen, Jeroen [1 ]
Sen, Shuvayu [2 ]
机构：
[1] MapiValues, Clin & Econ Evidence, Boston, MA USA
[2] Merck & Co Inc, Global Hlth Outcomes, Whitehouse Stn, NJ USA
来源：
OSTEOPOROSIS INTERNATIONAL | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：132 / 133
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness of a fixed dose combination of alendronate and cholecalciferol in the treatment and prevention of osteoporosis in the United Kingdom and-The Netherlands
    Jansen, Jeroen P.
    Giaugris, Sabine
    Bergman, Gert
    Sen, Shuvayu S.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (03) : 671 - 684
  • [2] COST-EFFECTIVENESS OF A FIXED DOSE COMBINATION OF ALENDRONATE 70 MG AND CHOLECALCIFEROL 5600 IU WEEKLY VERSUS IBANDRONATE IV INJECTION IN THE TREATMENT OF ESTABLISHED OSTEOPOROSIS IN AUSTRIA
    Jansen, J. P.
    Ghosh, S.
    Fan, T.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 386 - 386
  • [3] EFFECT OF ALENDRONATE COST ON THE COST-EFFECTIVENESS OF OSTEOPOROSIS SCREENING AND TREATMENT
    Nayak, Smita
    Mark
    GreenspanRoberts, Susan L. S.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 : S252 - S252
  • [4] Cost-effectiveness of vitamin D and calcium supplementation in the treatment of elderly women and men with osteoporosis
    Hiligsmann, Mickael
    Ben Sedrine, Wafa
    Bruyere, Olivier
    Evers, Silvia M.
    Rabenda, Veronique
    Reginster, Jean-Yves
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2015, 25 (01): : 20 - 25
  • [5] The cost-effectiveness of therapy with Teriparatide and alendronate in women with severe osteoporosis
    Liu, Hau
    Michaud, Kaleb
    Nayak, Smita
    Karpf, David B.
    Owens, Douglas K.
    Garber, Alan M.
    ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (11) : 1209 - 1217
  • [6] Fosamax® (alendronate sodium) and cholecalciferol (Vitamin D3) in the treatment of men and postmenopausal women with osteoporosis
    Chouha, F.
    Shulman, M.
    Liao, C.
    Koulis, T.
    Sampalis, J. S.
    Karaplis, A. C.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S340 - S340
  • [7] Impact of Generic Alendronate Cost on the Cost-Effectiveness of Osteoporosis Screening and Treatment
    Nayak, Smita
    Roberts, Mark S.
    Greenspan, Susan L.
    PLOS ONE, 2012, 7 (03):
  • [8] Cost-effectiveness of Fosamax® (alendronate) for the treatment of osteoporosis and prevention of fractures
    Johnell, O
    Jönsson, B
    Jönsson, L
    Black, D
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S9 - S9
  • [9] Cost-effectiveness of alendronate in the treatment of postmenopausal women in the UK
    Borgström, F
    Johnell, O
    Jönsson, B
    Kanis, J
    Kong, SX
    Sen, SS
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S13 - S13
  • [10] The cost-effectiveness of calcium and vitamin D supplementation in women with low dietary intake of these nutrients and at risk of osteoporosis
    Stevenson, MD
    Lloyd-Jones, M
    Brazier, JE
    Calvert, N
    Oakley, J
    Kanis, JA
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S87 - S88
12345